Breaking News Bar

Business News and Information

Emory researchers: 'Very encouraging' results in Covid-19 vaccine phase 1 trial

The vaccine produced "a good immune response," and trial participants suffered no serious adverse events, investigators reported. The second phase of the trial is ongoing and a third phase will launch this month.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear